MedPath

Eastern Cooperative Oncology Group

Eastern Cooperative Oncology Group logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
2012-01-01
Employees
51
Market Cap
-
Website
https://ecog-acrin.org

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 2
Completed
Conditions
Sarcoma
First Posted Date
2003-07-11
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
33
Registration Number
NCT00003008
Locations
🇺🇸

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Drug: Placebo
First Posted Date
2003-07-09
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
342
Registration Number
NCT00064350
Locations
🇺🇸

Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States

🇺🇸

Memorial Hospital, Carthage, Illinois, United States

🇺🇸

St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States

and more 138 locations

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 3
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2003-07-09
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00002878
Locations
🇺🇸

CCOP - Christiana Care Health Services, Wilmington, Delaware, United States

🇨🇦

CancerCare Manitoba, Winnipeg, Manitoba, Canada

🇨🇦

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada

and more 37 locations

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

Phase 2
Completed
Conditions
Esophageal Cancer
Interventions
Procedure: Minimally invasive esophagectomy (MIE)
First Posted Date
2003-07-09
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
110
Registration Number
NCT00063986
Locations
🇺🇸

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States

🇺🇸

Meeker County Memorial Hospital, Litchfield, Minnesota, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 38 locations

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Biological: interferon alpha
First Posted Date
2003-06-06
Last Posted Date
2023-07-07
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
37
Registration Number
NCT00062010
Locations
🇺🇸

CCOP - Columbus, Columbus, Ohio, United States

🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

HealthEast Cancer Care at St. Joseph's Hospital, Saint Paul, Minnesota, United States

and more 70 locations

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia

Phase 2
Terminated
Conditions
Lymphoma
Interventions
First Posted Date
2003-05-07
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
16
Registration Number
NCT00060346
Locations
🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States

and more 150 locations

Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
First Posted Date
2003-05-07
Last Posted Date
2013-06-24
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00059982
Locations
🇺🇸

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

🇺🇸

Tufts - New England Medical Center, Boston, Massachusetts, United States

🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

and more 7 locations

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Phase 3
Completed
Conditions
Fatigue
Anemia
Prostate Cancer
First Posted Date
2003-05-07
Last Posted Date
2023-06-15
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
282
Registration Number
NCT00060398
Locations
🇺🇸

Mercy Hospital and Medical Center, Chicago, Illinois, United States

🇺🇸

Swedish Covenant Hospital, Chicago, Illinois, United States

🇺🇸

Fox Chase Virtua Health Cancer Program at Virtua West Jersey, Voorhees, New Jersey, United States

and more 137 locations

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Phase 1
Completed
Conditions
Lung Cancer
First Posted Date
2003-04-30
Last Posted Date
2023-06-22
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00003649
Locations
🇺🇸

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

🇺🇸

CCOP - Green Bay, Green Bay, Wisconsin, United States

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Phase 2
Completed
Conditions
Bladder Cancer
First Posted Date
2003-04-18
Last Posted Date
2023-06-22
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
75
Registration Number
NCT00003129
Locations
🇺🇸

CCOP - Green Bay, Green Bay, Wisconsin, United States

🇺🇸

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States

🇺🇸

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States

and more 7 locations
© Copyright 2025. All Rights Reserved by MedPath